BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28366834)

  • 21. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
    Oji Y; Tatsumi N; Kobayashi J; Fukuda M; Ueda T; Nakano E; Saito C; Shibata S; Sumikawa M; Fukushima H; Saito A; Hojo N; Suzuki M; Hoshikawa T; Shimura T; Morii E; Oka Y; Hosen N; Komatsu K; Sugiyama H
    Mol Carcinog; 2015 Dec; 54(12):1758-71. PubMed ID: 25418835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.
    Wells J; Rivera MN; Kim WJ; Starbuck K; Haber DA
    Mol Cancer Res; 2010 Jul; 8(7):975-85. PubMed ID: 20571064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b).
    Wagner KD; Wagner N; Schley G; Theres H; Scholz H
    Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin.
    Kirschner KM; Sciesielski LK; Scholz H
    Pflugers Arch; 2010 Nov; 460(6):1051-61. PubMed ID: 20811903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
    Morrison AA; Venables JP; Dellaire G; Ladomery MR
    Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Wilms' tumor suppressor gene WT1 is negatively autoregulated.
    Rupprecht HD; Drummond IA; Madden SL; Rauscher FJ; Sukhatme VP
    J Biol Chem; 1994 Feb; 269(8):6198-206. PubMed ID: 8119964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
    Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
    Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
    McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
    Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
    Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
    Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.
    Ye Y; Raychaudhuri B; Gurney A; Campbell CE; Williams BR
    EMBO J; 1996 Oct; 15(20):5606-15. PubMed ID: 8896454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
    Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
    Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.
    Wagner N; Wagner KD; Theres H; Englert C; Schedl A; Scholz H
    Genes Dev; 2005 Nov; 19(21):2631-42. PubMed ID: 16264195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
    Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U
    Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilms' tumor suppressor gene (WT1) suppresses apoptosis by transcriptionally downregulating BAX expression in immature rat granulosa cells.
    Park M; Choi Y; Choi H; Roh J
    J Ovarian Res; 2014 Dec; 7():118. PubMed ID: 25491731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.
    Lee TH; Pelletier J
    Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.
    Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene.
    Sciesielski LK; Kirschner KM; Scholz H; Persson AB
    FEBS Lett; 2010 Nov; 584(22):4665-71. PubMed ID: 20974136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.